Literature DB >> 27237057

Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms.

Giuseppe Gaetano Loscocco1, Carmela Mannarelli1, Annalisa Pacilli1, Tiziana Fanelli1,2, Giada Rotunno1, Francesca Gesullo1, Giuditta Corbizi-Fattori1,2, Alessandro Maria Vannucchi1, Paola Guglielmelli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27237057     DOI： 10.1002/ajh.24437

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

Review 1.  The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.

Authors:  N Maslah; B Cassinat; E Verger; J-J Kiladjian; L Velazquez
Journal:  Leukemia       Date:  2017-05-09       Impact factor: 11.528

Review 2.  Myeloproliferative neoplasms: from origins to outcomes.

Authors:  Jyoti Nangalia; Anthony R Green
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  The Missing LNK: Evolution from Cytosis to Chronic Myelomonocytic Leukemia in a Patient with Multiple Sclerosis and Germline SH2B3 Mutation.

Authors:  Krishna Gundabolu; Bhavana J Dave; Carmelita J Alvares; Jeffrey J Cannatella; Vijaya R Bhatt; Lori J Maness; Zaid S Al-Kadhimi; Rana K Zabad; Allison M Cushman-Vokoun
Journal:  Case Rep Genet       Date:  2022-03-01

4.  Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms.

Authors:  Jean Pegliasco; Pierre Hirsch; Christophe Marzac; Françoise Isnard; Jean-Côme Meniane; Caroline Deswarte; Philippe Pellet; Céline Lemaitre; Gwendoline Leroy; Graciela Rabadan Moraes; Hélène Guermouche; Barbara Schmaltz-Panneau; Florence Pasquier; Chrystelle Colas; Patrick R Benusiglio; Odile Bera; Jean-Henri Bourhis; Eolia Brissot; Olivier Caron; Samy Chraibi; Pascale Cony-Makhoul; Christine Delaunay-Darivon; Simona Lapusan; Flore Sicre de Fontbrune; Pascal Fuseau; Albert Najman; William Vainchenker; François Delhommeau; Jean-Baptiste Micol; Isabelle Plo; Christine Bellanné-Chantelot
Journal:  Leukemia       Date:  2021-06-25       Impact factor: 11.528
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.